XML 32 R18.htm IDEA: XBRL DOCUMENT v3.25.0.1
Goodwill and Intangible Assets
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets
8.
Goodwill and Intangible Assets

There have been no changes in the carrying amount of goodwill since its recognition in 2015. In conjunction with our organizational realignment in 2024, we allocated goodwill among our two reporting units using a relative fair value approach. Goodwill allocated to the MRD and Immune Medicine reporting units as of December 31, 2024 was $96.4 million and $22.6 million, respectively.

Intangible assets subject to amortization as of December 31, 2024 and 2023 consisted of the following (in thousands):

 

 

 

December 31, 2024

 

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net Carrying Amount

 

Acquired developed technology

 

$

20,000

 

 

$

(16,641

)

 

$

3,359

 

Purchased intellectual property

 

 

325

 

 

 

(259

)

 

 

66

 

Balance at December 31, 2024

 

$

20,325

 

 

$

(16,900

)

 

$

3,425

 

 

 

 

December 31, 2023

 

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net Carrying Amount

 

Acquired developed technology

 

$

20,000

 

 

$

(14,970

)

 

$

5,030

 

Purchased intellectual property

 

 

325

 

 

 

(227

)

 

 

98

 

Balance at December 31, 2023

 

$

20,325

 

 

$

(15,197

)

 

$

5,128

 

 

The developed technology was acquired in connection with our acquisition of Sequenta, Inc. in 2015. The remaining balance of the acquired developed technology and the purchased intellectual property is expected to be amortized over the next 2.0 years, approximately.

As of December 31, 2024, expected future amortization expense for intangible assets was as follows (in thousands):

 

 

2025

 

$

1,699

 

2026

 

 

1,699

 

2027

 

 

27

 

Total future amortization expense

 

$

3,425